{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T01:19:49Z","timestamp":1776388789308,"version":"3.51.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T00:00:00Z","timestamp":1632614400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K12DA043490"],"award-info":[{"award-number":["K12DA043490"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Stimulant use has increased across the US, with concomitant opioid and methamphetamine use doubling between 2011 and 2017. Shifting patterns of polysubstance use have led to rising psychostimulant-involved deaths. While it is known that individuals who use methamphetamine require greater access to treatment, there is still little known about methamphetamine use and treatment among individuals who are already engaged in outpatient substance use treatment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>To characterize care-engaged individuals who use methamphetamine to guide harm reduction and treatment strategies.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Retrospective cohort study of individuals at a large academic medical center in Massachusetts with \u2265\u20092 positive methamphetamine oral fluid toxicology tests between August 2019 and January 2020. We performed descriptive analysis of sociodemographic, medical, and drug use characteristics and a comparative analysis of injection methamphetamine use versus other routes of use.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Included were 71 individuals [56 male (80%), 66 non-Hispanic white (94%), median age 36 (IQR 30\u201342)]. Nearly all had opioid (94%) and stimulant use disorder (92%). Most had (93%) or were (83%) being treated with medications for opioid use disorder, but few received pharmacologic treatment for methamphetamine use disorder (24%). None received contingency management treatment.<\/jats:p>\n                <jats:p>People who inject methamphetamine (68%) were more likely to have a history of overdose (91% vs. 70%; p\u2009=\u20090.02), have HCV (94% vs. 52%; p\u2009&lt;\u20090.01), use fentanyl (93% vs. 65%; p\u2009=\u20090.02), and engage in sex work (19% vs. 0%; p\u2009=\u20090.03) compared to those who used via other routes. Both groups had prevalent homelessness (88% vs. 73%; p\u2009=\u20090.15), incarceration (81% vs. 64%; p\u2009=\u20090.11), depression (94% vs. 87%; p\u2009=\u20090.34), and bacteremia (27% vs. 22%; p\u2009=\u20090.63).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Individuals in our study had high prevalence of polysubstance use, particularly concomitant methamphetamine and opioid use. Individuals who were well connected to substance use treatment for their opioid use were still likely to be undertreated for their methamphetamine use disorder and would benefit from greater access to contingency management treatment, harm reduction resources, and resources to address adverse social determinants of health.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-021-00267-1","type":"journal-article","created":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T20:04:40Z","timestamp":1632686680000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Care-engaged individuals with polysubstance use in Northeastern US are undertreated for methamphetamine use disorder: a retrospective cohort study"],"prefix":"10.1186","volume":"16","author":[{"given":"Mimi","family":"Yen Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Alba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julian","family":"Mitton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2554-8422","authenticated-orcid":false,"given":"Benjamin","family":"Bearnot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,26]]},"reference":[{"key":"267_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","volume":"193","author":"MS Ellis","year":"2018","unstructured":"Ellis MS, Kasper ZA, Cicero TJ. Twin epidemics: the surging rise of methamphetamine use in chronic opioid users. Drug Alcohol Depend. 2018;193:14\u201320.","journal-title":"Drug Alcohol Depend"},{"key":"267_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","volume":"71","author":"D Ciccarone","year":"2019","unstructured":"Ciccarone D. The triple wave epidemic: supply and demand drivers of the US opioid overdose crisis. Int J Drug Policy. 2019;71:183\u20138.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"267_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/JAN.0000000000000298","volume":"30","author":"SA Fogger","year":"2019","unstructured":"Fogger SA. Methamphetamine use. A New wave in the opioid crisis? J Addict Nurs. 2019;30(3):219\u201323.","journal-title":"J Addict Nurs"},{"issue":"6","key":"267_CR4","doi-asserted-by":"publisher","first-page":"e183758","DOI":"10.1001\/jamanetworkopen.2018.3758","volume":"1","author":"TNA Winkelman","year":"2018","unstructured":"Winkelman TNA, Admon LK, Jennings L, Shippee ND, Richardson CR, Bart G. Evaluation of amphetamine-related hospitalizations and associated clinical outcomes and costs in the United States. JAMA Netw Open. 2018;1(6):e183758\u2013e183758.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"267_CR5","doi-asserted-by":"publisher","first-page":"e0242165","DOI":"10.1371\/journal.pone.0242165","volume":"9","author":"J Capizzi","year":"2020","unstructured":"Capizzi J, Leahy J, Wheelock H, Garcia J, Strnad L, Sikka M, et al. Population-based trends in hospitalizations due to injection drug use-related serious bacterial infections, Oregon, 2008 to 2018. PLOS ONE. 2020;9(11):e0242165.","journal-title":"PLOS ONE"},{"issue":"9","key":"267_CR6","first-page":"1","volume":"67","author":"H Hedegaard","year":"2018","unstructured":"Hedegaard H, Bastian BA, Trinidad JP, Spencer M, Warner M. Drugs most frequently involved in drug overdose deaths: United States, 2011\u20132016. Natl Vital Stat Rep Cent Dis Control Prev Natl Cent Health Stat Natl Vital Stat Syst. 2018;67(9):1\u201314.","journal-title":"Natl Vital Stat Rep Cent Dis Control Prev Natl Cent Health Stat Natl Vital Stat Syst"},{"issue":"10122","key":"267_CR7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0140-6736(18)30319-2","volume":"24","author":"The Lancet","year":"2018","unstructured":"The Lancet. Opioids and methamphetamine: a tale of two crises. Lancet Lond Engl. 2018;24(10122):713.","journal-title":"Lancet Lond Engl"},{"key":"267_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000695","author":"S Wakeman","year":"2020","unstructured":"Wakeman S, Flood J, Ciccarone D. Rise in presence of methamphetamine in oral fluid toxicology tests among outpatients in a large healthcare setting in the Northeast. J Addict Med. 2020. https:\/\/doi.org\/10.1097\/ADM.0000000000000695.","journal-title":"J Addict Med"},{"key":"267_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.drugalcdep.2019.03.014","volume":"01","author":"JA Barocas","year":"2019","unstructured":"Barocas JA, Wang J, Marshall BDL, LaRochelle MR, Bettano A, Bernson D, et al. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug Alcohol Depend. 2019;01:59\u201363.","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"267_CR10","first-page":"16","volume":"68","author":"H Hedegaard","year":"2017","unstructured":"Hedegaard H, Bastian BA, Trinidad JP, Spencer MR, Warner M. Regional differences in the drugs most frequently involved in drug overdose deaths: United States. Natl Vital Stat Rep. 2017;68(12):16.","journal-title":"Natl Vital Stat Rep"},{"issue":"6408","key":"267_CR11","first-page":"361","volume":"21","author":"H Jalal","year":"2018","unstructured":"Jalal H, Buchanich JM, Roberts MS, Balmert LC, Zhang K, Burke DS. Changing dynamics of the drug overdose epidemic in the United States from 1979 through 2016. Science. 2018;21(6408):361.","journal-title":"Science"},{"issue":"2","key":"267_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/add.14812","volume":"115","author":"CM Jones","year":"2020","unstructured":"Jones CM, Underwood N, Compton WM. Increases in methamphetamine use among heroin treatment admissions in the United States, 2008\u201317. Addiction. 2020;115(2):347\u201353.","journal-title":"Addiction"},{"key":"267_CR13","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jsat.2019.10.005","volume":"1","author":"JI Tsui","year":"2020","unstructured":"Tsui JI, Mayfield J, Speaker EC, Yakup S, Ries R, Funai H, et al. Association between methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine. J Subst Abuse Treat. 2020;1:80\u20135.","journal-title":"J Subst Abuse Treat"},{"key":"267_CR14","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7006a4","author":"CL Mattson","year":"2021","unstructured":"Mattson CL. Trends and geographic patterns in drug and synthetic opioid overdose deaths\u2014United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep. 2021. https:\/\/doi.org\/10.15585\/mmwr.mm7006a4.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"267_CR15","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.annemergmed.2020.06.046","volume":"76","author":"MC Chawarski","year":"2020","unstructured":"Chawarski MC, Hawk K, Edelman EJ, O\u2019Connor P, Owens P, Martel S, et al. Use of amphetamine-type stimulants among emergency department patients with untreated opioid use disorder. Ann Emerg Med. 2020;76(6):782\u20137.","journal-title":"Ann Emerg Med"},{"issue":"3","key":"267_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/09595230801919486","volume":"27","author":"R McKetin","year":"2008","unstructured":"McKetin R, Ross J, Kelly E, Baker A, Lee N, Lubman DI, et al. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants. Drug Alcohol Rev. 2008;27(3):277\u201385.","journal-title":"Drug Alcohol Rev"},{"issue":"Supplement_5","key":"267_CR17","doi-asserted-by":"publisher","first-page":"S213","DOI":"10.1093\/infdis\/jiaa432","volume":"222","author":"A Levitt","year":"2020","unstructured":"Levitt A, Mermin J, Jones CM, See I, Butler JC. Infectious diseases and injection drug use: public health burden and response. J Infect Dis. 2020;222(Supplement_5):S213-7.","journal-title":"J Infect Dis"},{"key":"267_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-018-3408-y","author":"M Neils","year":"2018","unstructured":"Neils M, McQuade E, Scheld W, Dillingham R. Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study. BMC Infect Dis. 2018. https:\/\/doi.org\/10.1186\/s12879-018-3408-y.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"267_CR19","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/j.1360-0443.2007.01847.x","volume":"102","author":"BJ Iritani","year":"2007","unstructured":"Iritani BJ, Hallfors DD, Bauer DJ. Crystal methamphetamine use among young adults in the USA. Addict Abingdon Engl. 2007;102(7):1102\u201313.","journal-title":"Addict Abingdon Engl"},{"issue":"2","key":"267_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1007\/s11121-010-0197-y","volume":"12","author":"BDL Marshall","year":"2011","unstructured":"Marshall BDL, Wood E, Shoveller JA, Buxton JA, Montaner JSG, Kerr T, Individual. Social and environmental factors associated with initiating methamphetamine injection: implications for drug use and HIV prevention strategies. Prev Sci Off J Soc Prev Res. 2011;12(2):173\u201380.","journal-title":"Prev Sci Off J Soc Prev Res"},{"key":"267_CR21","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6912a1","author":"CM Jones","year":"2020","unstructured":"Jones CM. Patterns and characteristics of methamphetamine use among adults\u2014United States, 2015\u20132018. MMWR Morb Mortal Wkly Rep. 2020. https:\/\/doi.org\/10.15585\/mmwr.mm6912a1.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"267_CR22","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s40263-020-00711-x","volume":"34","author":"KJ Siefried","year":"2020","unstructured":"Siefried KJ, Acheson LS, Lintzeris N, Ezard N. Pharmacological treatment of methamphetamine\/amphetamine dependence: a systematic review. CNS Drugs. 2020;34(4):337\u201365.","journal-title":"CNS Drugs"},{"issue":"12","key":"267_CR23","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1111\/add.14755","volume":"114","author":"B Chan","year":"2019","unstructured":"Chan B, Freeman M, Kondo K, Ayers C, Montgomery J, Paynter R, et al. Pharmacotherapy for methamphetamine\/amphetamine use disorder\u2014a systematic review and meta-analysis. Addiction. 2019;114(12):2122\u201336.","journal-title":"Addiction"},{"key":"267_CR24","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2147\/SAR.S138439","volume":"9","author":"SM McPherson","year":"2018","unstructured":"McPherson SM, Burduli E, Smith CL, Herron J, Oluwoye O, Hirchak K, et al. A review of contingency management for the treatment of substance-use disorders: adaptation for underserved populations, use of experimental technologies, and personalized optimization strategies. Subst Abuse Rehabil. 2018;9:43\u201357.","journal-title":"Subst Abuse Rehabil"},{"key":"267_CR25","doi-asserted-by":"publisher","first-page":"108307","DOI":"10.1016\/j.drugalcdep.2020.108307","volume":"1","author":"HD Brown","year":"2020","unstructured":"Brown HD, DeFulio A. Contingency management for the treatment of methamphetamine use disorder: a systematic review. Drug Alcohol Depend. 2020;1:108307.","journal-title":"Drug Alcohol Depend"},{"key":"267_CR26","first-page":"380","volume-title":"Contingency management in substance abuse treatment","author":"ST Higgins","year":"2007","unstructured":"Higgins ST, Silverman K, Heil SH. Contingency management in substance abuse treatment. New York: The Guilford Press; 2007. p. 380."},{"key":"267_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.1969","author":"HA Bol\u00edvar","year":"2021","unstructured":"Bol\u00edvar HA, Klemperer EM, Coleman SRM, DeSarno M, Skelly JM, Higgins ST. Contingency management for patients receiving medication for opioid use disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2021. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.1969.","journal-title":"JAMA Psychiatry"},{"issue":"8","key":"267_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1037\/adb0000287","volume":"31","author":"NM Petry","year":"2017","unstructured":"Petry NM, Alessi SM, Olmstead TA, Rash CJ, Zajac K. Contingency management treatment for substance use disorders: how far has it come, and where does it need to go? Psychol Addict Behav J Soc Psychol Addict Behav. 2017;31(8):897\u2013906.","journal-title":"Psychol Addict Behav J Soc Psychol Addict Behav"},{"issue":"1","key":"267_CR29","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/jat\/bkx079","volume":"42","author":"D Borg","year":"2018","unstructured":"Borg D, Kolb E, Lantigua C, Stripp R. Chiral analysis of methamphetamine in oral fluid samples: a method to distinguish licit from illicit drug use. J Anal Toxicol. 2018;42(1):25\u201332.","journal-title":"J Anal Toxicol"},{"issue":"1","key":"267_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/jat\/34.2.103","volume":"34","author":"CR Crooks","year":"2010","unstructured":"Crooks CR, Brown S, Roche DAT, Immunoassay. Sensitivity and specificity testing for amphetamines, cocaine, and opiates in oral fluid. J Anal Toxicol. 2010;34(1):103\u20139.","journal-title":"J Anal Toxicol"},{"issue":"2","key":"267_CR31","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"267_CR32","unstructured":"Substance Abuse and Mental Health Services Administration. Results from the 2018 National Survey on Drug Use and Health. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration. 2019.\u00a0\u00a0https:\/\/www.samhsa.gov\/data\/report\/2018-nsduh-detailed-tables. Accessed 11 Feb 2021."},{"key":"267_CR33","doi-asserted-by":"publisher","DOI":"10.1377\/hblog20200305.965186\/full\/","author":"JE Glass","year":"2021","unstructured":"Glass JE, Nunes EV, Bradley KA. contingency management. A highly effective treatment for substance use disorders and the legal barriers that stand in its way. JAMA Netw Open. 2021. https:\/\/doi.org\/10.1377\/hblog20200305.965186\/full\/.","journal-title":"JAMA Netw Open"},{"key":"267_CR34","doi-asserted-by":"publisher","first-page":"108193","DOI":"10.1016\/j.drugalcdep.2020.108193","volume":"1","author":"B Chan","year":"2020","unstructured":"Chan B, Freeman M, Ayers C, Korthuis PT, Paynter R, Kondo K, et al. A systematic review and meta-analysis of medications for stimulant use disorders in patients with co-occurring opioid use disorders. Drug Alcohol Depend. 2020;1:108193.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"267_CR35","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1056\/NEJMoa2020214","volume":"14","author":"MH Trivedi","year":"2021","unstructured":"Trivedi MH, Walker R, Ling W, dela Cruz A, Sharma G, Carmody T, et al. Bupropion and naltrexone in methamphetamine use disorder. N Engl J Med. 2021;14(2):140\u201353.","journal-title":"N Engl J Med"},{"issue":"3","key":"267_CR36","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1001\/jamapsychiatry.2019.3655","volume":"77","author":"PO Coffin","year":"2020","unstructured":"Coffin PO, Santos G-M, Hern J, Vittinghoff E, Walker JE, Matheson T, et al. Effects of mirtazapine for methamphetamine use disorder among cisgender men and transgender women who have sex with men: a placebo-controlled randomized clinical trial. JAMA Psychiatry. 2020;77(3):246\u201355.","journal-title":"JAMA Psychiatry"},{"issue":"3","key":"267_CR37","first-page":"205","volume":"23","author":"NM Petry","year":"2014","unstructured":"Petry NM, DePhilippis D, Rash CJ, Drapkin M, McKay JR. Nationwide dissemination of contingency management: the Veterans Administration initiative. Am J Addict Am Acad Psychiatr Alcohol Addict. 2014;23(3):205\u201310.","journal-title":"Am J Addict Am Acad Psychiatr Alcohol Addict"},{"issue":"1","key":"267_CR38","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","volume":"110","author":"C Alpren","year":"2020","unstructured":"Alpren C, Dawson EL, John B, Cranston K, Panneer N, Fukuda HD, et al. Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs\u2014Massachusetts, 2015\u20132018. Am J Public Health. 2020;110(1):37\u201344.","journal-title":"Am J Public Health"},{"issue":"3","key":"267_CR39","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s11904-018-0396-x","volume":"15","author":"KM Rich","year":"2018","unstructured":"Rich KM, Bia J, Altice FL, Feinberg J. Integrated models of care for individuals with opioid use disorder: how do we prevent HIV and HCV? Curr HIV\/AIDS Rep. 2018;15(3):266\u201375.","journal-title":"Curr HIV\/AIDS Rep"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-021-00267-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-021-00267-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-021-00267-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,26]],"date-time":"2021-09-26T20:14:34Z","timestamp":1632687274000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-021-00267-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,26]]},"references-count":39,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["267"],"URL":"https:\/\/doi.org\/10.1186\/s13722-021-00267-1","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,26]]},"assertion":[{"value":"19 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was provided by the Partners Massachusetts General Brigham IRB Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"57"}}